Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122663413 | 12266341 | 3 | F | 20160405 | 20160607 | 20160414 | 20160706 | EXP | US-ASTRAZENECA-2016SE37426 | ASTRAZENECA | 29623.00 | DY | F | Y | 64.40000 | KG | 20160706 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122663413 | 12266341 | 1 | PS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 202450 | 1 | DF | INHALATION POWDER | BID | |||||||
| 122663413 | 12266341 | 2 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | 0 | 25 | MG | BID | ||||||||
| 122663413 | 12266341 | 3 | SS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | U | U | 0 | 2 | DF | INHALATION POWDER | BID | |||||
| 122663413 | 12266341 | 4 | SS | PULMICORT FLEXHALER | BUDESONIDE | 1 | Respiratory (inhalation) | U | U | 0 | 2 | DF | INHALATION POWDER | BID | |||||
| 122663413 | 12266341 | 5 | C | ELIQUIS | APIXABAN | 1 | Oral | 0 | 2.5 | MG | BID | ||||||||
| 122663413 | 12266341 | 6 | C | ELIQUIS | APIXABAN | 1 | Oral | 0 | 2.5 | MG | BID | ||||||||
| 122663413 | 12266341 | 7 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 0 | .125 | MG | QD | ||||||||
| 122663413 | 12266341 | 8 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 0 | .125 | MG | QD | ||||||||
| 122663413 | 12266341 | 9 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 122663413 | 12266341 | 10 | C | RANITIDINE HCL | RANITIDINE HYDROCHLORIDE | 1 | Oral | 0 | 300 | MG | QD | ||||||||
| 122663413 | 12266341 | 11 | C | CENTRUM | VITAMINS | 1 | Oral | DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122663413 | 12266341 | 1 | Lung disorder |
| 122663413 | 12266341 | 2 | Cardiac disorder |
| 122663413 | 12266341 | 3 | Lung disorder |
| 122663413 | 12266341 | 4 | Dyspnoea |
| 122663413 | 12266341 | 5 | Heart rate irregular |
| 122663413 | 12266341 | 6 | Atrial fibrillation |
| 122663413 | 12266341 | 7 | Cardiac disorder |
| 122663413 | 12266341 | 8 | Atrial fibrillation |
| 122663413 | 12266341 | 10 | Lung disorder |
| 122663413 | 12266341 | 11 | Vitamin supplementation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122663413 | 12266341 | OT |
| 122663413 | 12266341 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122663413 | 12266341 | Drug dose omission | |
| 122663413 | 12266341 | Dysphonia | |
| 122663413 | 12266341 | Lung disorder | |
| 122663413 | 12266341 | Organising pneumonia | |
| 122663413 | 12266341 | Product quality issue | |
| 122663413 | 12266341 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122663413 | 12266341 | 1 | 201504 | 0 | ||
| 122663413 | 12266341 | 3 | 201502 | 0 | ||
| 122663413 | 12266341 | 4 | 201502 | 0 | ||
| 122663413 | 12266341 | 5 | 201504 | 0 | ||
| 122663413 | 12266341 | 6 | 201504 | 0 | ||
| 122663413 | 12266341 | 7 | 201504 | 0 | ||
| 122663413 | 12266341 | 8 | 201504 | 0 |